Vicebio
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $117.5M
Overview
A biotech company developing next-generation vaccines for infectious diseases.
Infectious Diseases
Technology Platform
Focused on developing innovative vaccine platforms, potentially involving novel antigen design or delivery systems, to generate superior immune responses.
Funding History
3Total raised:$117.5M
Venture$100M
Series A$15M
Seed$2.5M
Opportunities
Global emphasis on pandemic preparedness and continued need for improved vaccines against persistent infectious diseases creates significant funding and partnership potential.
Risk Factors
Vaccine development is costly, high-risk, and faces intense regulatory scrutiny, with a high bar for demonstrating superiority or equivalence to established vaccines.
Competitive Landscape
Enters a crowded and highly competitive vaccine market, competing with large pharma and numerous biotechs across multiple technological approaches.